Pharmafile Logo

Boost Publication Collaboration Virtually – Engaging Your Advisors Creatively

Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first tip of this top 10 tips series.

Discover how to revolutionize publication planning, development, and collaboration in the digital age. Empower your KOLs, DOLs, MSLs, HCPs, and other geographically dispersed stakeholders to co-create impactful publications, including peer-reviewed articles, guidelines, and educational materials. Learn how asynchronous and synchronous tools streamline every step of the process, from idea conception to final dissemination, resulting in faster results and higher engagement rates compared to traditional in-person meetings.

  1. Learn how to leverage digital solutions to enhance collaboration on publications, including:
  • Co-creating peer-reviewed articles and guidelines
  • Streamlining literature reviews and draft development
  • Utilizing asynchronous and synchronous tools for efficient communication
  • Increasing engagement with geographically dispersed advisors

Explore how the Impetus InSite Platform® can transform your publication process.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

#VirtualCollaboration #PublicationPlanning #AdvisoryBoards #DigitalEngagement #LifeSciences #Pharma #ImpetusDigital

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Health literacy in the time of COVID-19

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Helping Caregivers Stay Organized, Secure, and Informed

Audrey Bond, Founder & CEO of Vaultt, discusses her inspiration behind founding the company, how Vaultt is revolutionizing data-sharing in Canada, common biosecurity and data privacy concerns, her experience with...

Transitioning to the “New Normal”: What This Means for Oncology Care

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US...

Making Wearable Technology Scalable and Adoptable

Ilaria Varoli, EVP of Myant Inc., explores Textile Computing™ for remote monitoring, health assessments, pediatric and maternal care, temperature regulation, monitoring of athlete performance, and much more.

Courageous Conversation ep.12: Not Going Back: How COVID Has Changed Clinical Trials

Natalie Yeadon, CEO & Co-Founder at Impetus Digital, provides insight into how COVID has changed clinical trials.

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

Parallel HCP-Patient Advisory Boards: A Customer Story

Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards.

Courageous Conversation ep.10: Facial Recognition Software in Healthcare

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on Facial Recognition Software in Healthcare.

Transforming the Future of Health & Aging from a Global Health & Social Impact Approach

Dr. Zayna Khayat, Future Strategist at SE Health, dives into the future of aging and healthcare in Canada, including the roles of emerging technologies, the shift to people-powered healthcare, and...

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve...